High-throughput identification of repurposable neuroactive drugs with potent anti-glioblastoma activity
Sohyon Lee(ETH Zurich), Berend Snijder(ETH Zurich), Patrick G. A. Pedrioli(SIB Swiss Institute of Bioinformatics), Zuzanna Lottenbach(ETH Zurich), Sven Baumann(University of Bern), Tobias Weiß(University of Zurich), Michael Weller(University Hospital of Zurich), Yasmin Festl(ETH Zurich), Anna Maria Zeitlberger(Kantonsspital St. Gallen), Bartłomiej Augustynek(University of Bern), Flavio Vasella(University of Zurich), Sandra Goetze(ETH Zurich), Marian C. Neidert(University of St.Gallen), Michel Bihl(University Hospital of Zurich), Alicia Buck(Unknown), Daniel S. Kirschenbaum(University of Zurich), David Pentón(University of Zurich), Bernd Wollscheid(University of Zurich), Julien Mena(ETH Zurich), Matthias A. Hediger(University of Bern), Elisabeth J. Rushing(University Hospital of Zurich), Marcel Bühler(University of Zurich), Rebekka Wegmann(ETH Zurich), Miaomiao Sun(University of Zurich), Audrey van Drogen(SIB Swiss Institute of Bioinformatics)
Cited by 68
Related Papers
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k